Katherine Stephans

913 total citations
7 papers, 702 citations indexed

About

Katherine Stephans is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Katherine Stephans has authored 7 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Katherine Stephans's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Immunotherapy and Immune Responses (3 papers). Katherine Stephans is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Immunotherapy and Immune Responses (3 papers). Katherine Stephans collaborates with scholars based in United States and United Kingdom. Katherine Stephans's co-authors include Robert H. Vonderheide, John G. Gribben, Lee M. Nadler, Karen S. Anderson, William C. Hahn, Kara M. Hoar, Joachim L. Schultze, David C. Fisher, Susan M. Domchek and Robert J. Soiffer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Katherine Stephans

7 papers receiving 693 citations

Peers

Katherine Stephans

IMMUN

ONCOL

GENET

MB

PFM

Shingo Urata Japan

Selda Samakoglu United States

Volker Diehl Germany

Christelle Dousset France

Nongnit Lewin Sweden

Betty Li United States

Evgeny Arons United States

RW Schroff United States

Andreas Draube Germany

Hans G. Drexler Germany

Shingo Urata Japan

Katherine Stephans

409 ×0.9

IMMUN

276 ×1.1

ONCOL

206 ×1.0

GENET

257 ×1.3

MB

127 ×0.7

PFM

Citations per year, relative to Katherine Stephans Katherine Stephans (= 1×) peers Shingo Urata

Countries citing papers authored by Katherine Stephans

Since Specialization

Citations

This map shows the geographic impact of Katherine Stephans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Stephans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Stephans more than expected).

Fields of papers citing papers by Katherine Stephans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Stephans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Stephans. The network helps show where Katherine Stephans may publish in the future.

Co-authorship network of co-authors of Katherine Stephans

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Stephans. A scholar is included among the top collaborators of Katherine Stephans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Stephans. Katherine Stephans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Brown, Jennifer R., Haesook T. Kim, Shuli Li, et al.. (2006). Predictors of Improved Progression-Free Survival After Nonmyeloablative Allogeneic Stem Cell Transplantation for Advanced Chronic Lymphocytic Leukemia. Biology of Blood and Marrow Transplantation. 12(10). 1056–1064. 71 indexed citations

2.

Gribben, John G., et al.. (2005). Fludarabine and Alemtuzumab Versus Fludarabine and Rituximab in the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia: Results from a Phase II Study.. Blood. 106(11). 5046–5046. 3 indexed citations

3.

Gribben, John G., David Zahrieh, Katherine Stephans, et al.. (2005). Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Blood. 106(13). 4389–4396. 160 indexed citations

4.

Vonderheide, Robert H., Susan M. Domchek, Joachim L. Schultze, et al.. (2004). Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes. Clinical Cancer Research. 10(3). 828–839. 205 indexed citations

5.

Friedberg, Jonathan W., Sigui Li, Helen Kim, et al.. (2003). Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo. Leukemia Research. 28(2). 139–147. 18 indexed citations

6.

Vonderheide, Robert H., Joachim L. Schultze, Karen S. Anderson, et al.. (2001). Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.. PubMed. 61(23). 8366–70. 64 indexed citations

7.

Vonderheide, Robert H., Janice P. Dutcher, Jeanne E. Anderson, et al.. (2001). Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients. Journal of Clinical Oncology. 19(13). 3280–3287. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact